Observatory · observe first
Follow the allocation change
Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.
Historical time machine
Historical observation
20182026
1 · Sector
Weight and 12M allocation change
2 · Industry
Inside Health Care
Pharmaceuticals6.10%+0.50 ppBiotechnology2.70%-0.49 ppHealth Care Equipment3.38%+0.45 ppLife Sciences Tools & Services1.87%+0.34 ppHealth Care Services0.95%+0.32 ppManaged Health Care2.12%+0.22 ppHealth Care Distributors0.36%-0.11 ppHealth Care Facilities0.26%+0.05 ppHealth Care Supplies0.15%+0.01 ppHealth Care Technology0.00%+0.00 pp
3 · Sub-industry
Inside Biotechnology
Biotechnology · weight
2.70%
Industry change · 12M
-0.49 pp
Biotechnology · contribution
-0.495 pp
Company participation
100%
of industry constituents above their 6M weight average
4 · Companies driving this sub-industry
Mar 2019 · sorted by absolute contribution to 12-month change
| Company | Country | Market cap | Universe weight | 3M contribution | 12M contribution | 12M price return | Above 6M weight average |
|---|---|---|---|---|---|---|---|
| AbbVie → ABBV | United States | $118.9bn | 0.683% | +0.187 pp | -0.239 pp | -11.1% | Yes |
| Gilead Sciences → GILD | United States | $82.9bn | 0.476% | +0.187 pp | -0.130 pp | -10.8% | Yes |
| Biogen → BIIB | United States | $46.5bn | 0.267% | +0.050 pp | -0.088 pp | -13.7% | Yes |
| Amgen → AMGN | United States | $118.2bn | 0.679% | +0.236 pp | -0.075 pp | +14.7% | Yes |
| Regeneron Pharmaceuticals → REGN | United States | $38.6bn | 0.222% | +0.096 pp | +0.023 pp | +19.2% | Yes |
| Vertex Pharmaceuticals → VRTX | United States | $47.0bn | 0.270% | +0.119 pp | +0.016 pp | +12.9% | Yes |
| Incyte → INCY | United States | $18.4bn | 0.106% | +0.057 pp | -0.002 pp | +3.2% | Yes |
Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.